Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
153 |
|
Actual shortage: | 6 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 5 (3%) | |
Resolved: | 141 (92%) | |
Discontinuation Reports |
51 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 51 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-06-23 | 2017-07-11 | 13861 |
TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-07-27 | 2017-09-13 | 17414 |
TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-09-18 | 2017-11-02 | 22359 |
TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2017-09-05 | 2017-09-14 | 20969 |
TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2022-07-21 | 2022-08-06 | 165184 |
TOBREX | .3% | SOLUTION | Resolved | 2017-09-05 | 2017-09-14 | 20963 |
TOBREX | .3% | SOLUTION | Resolved | 2018-12-11 | 2019-02-05 | 69257 |
TOBREX | 3MG | OINTMENT | Resolved | 2018-01-08 | 2018-01-30 | 35259 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-01-08 | 2019-01-28 | 71609 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-02-11 | 2019-03-09 | 75340 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-03-11 | 2019-04-06 | 78252 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-04-08 | 2019-04-26 | 80771 |
TOBREX | 3MG | OINTMENT | Resolved | 2019-06-21 | 2019-09-06 | 87200 |
TOBREX | 0.3% | OINTMENT | Resolved | 2020-09-08 | 2021-02-24 | 123888 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-01-08 | 2018-02-08 | 35254 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-03-13 | 2018-04-25 | 42773 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2019-12-16 | 2019-12-19 | 101440 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-01-20 | 2020-04-17 | 103742 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114097 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-07 | 128052 |
LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-12-08 | 128056 |
LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-26 | 2020-11-26 | 128967 |
LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-07 | 128059 |
LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-06 | 2020-11-06 | 128062 |
LOTENSIN 20MG | 20MG | TABLET | Discontinued | 2017-09-27 | 2018-08-29 | 23762 |
LOTENSIN 5MG | 5MG | TABLET | Discontinued | 2017-07-10 | 2017-09-26 | 15053 |
ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
RITALIN 10MG | 10MG | TABLET | Discontinued | 2022-02-08 | 2022-05-11 | 154449 |
RITALIN 20MG | 20MG | TABLET | Discontinued | 2019-07-22 | 2019-08-01 | 89771 |
RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-02-08 | 2022-04-05 | 154439 |
SANDOSTATIN | 200MCG | SOLUTION | Discontinued | 2022-02-08 | 2022-03-07 | 154429 |
SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |
SEBIVO | 600MG | TABLET | Discontinued | 2019-07-10 | 2019-11-06 | 89042 |
TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
TEGRETOL CHEWTABS 100 MG | 100MG | TABLET (CHEWABLE) | Discontinued | 2017-09-27 | 2017-09-27 | 23765 |
TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |
TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |